Perhaps in part, out of relief that the coronavirus scare is being nipped in the bud (if that is the case, of course), health-care small-cap issues enjoyed their share Tuesday of adulation.
Vancouver-based Else Nutrition Holdings, (TSX-Venture:BABY) focusing on developing and marketing a real alternative to dairy-based infant nutrition, signed a five-year production Memorandum of Understanding with a leading U.S. based organic baby formula producer. Else and the partner hope to have the deal done by end of the current quarter.
Else will invest about $500,000 U.S. in a dedicated packaging and manufacturing line for its products.
BABY hopped by a nickel, or 7.8%, to 69 cents, on 136,000 shares.
Meanwhile, Sugarland, Texas-based Neutra Corp. (OTC:NTRR) trumpeted Tuesday a new round of private equity just after the New Year that the company intends to use in its ongoing campaign to become a vertically integrated producer, manufacturer and distributor of hemp-based CBD health products.
Said the company CEO "This funding round gives us the ability to pursue our strategies and goals, as well as potentially expand our vision for the future. We had a very successful 2019; this private funding will help us towards an equally accomplished 2020."
NTRR gained 33.3% to $0.008, on more than 38 million shares.
